(VIANEWS) – NV5 Global (NVEE), Ingersoll (IR), Option Care Health (OPCH) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. NV5 Global (NVEE)
17.5% sales growth and 6.96% return on equity
NV5 Global, Inc. provides professional and technical engineering and consulting services to public and private sector clients in the infrastructure, utility services, construction, real estate, and environmental markets in the United States and internationally. It operates through three segments: Infrastructure; Building, Technology & Sciences; and Geospatial Solutions. The company offers site selection and planning, design, water resources, transportation, structural engineering, land development, surveying, power delivery, building code compliance, and other services; and construction materials testing and engineering, geotechnical engineering and consulting, and forensic consulting services. It also provides governmental outsourcing and consulting, and technical outsourcing services; and geospatial data analytic and mapping services. In addition, the company offers mechanical, electrical, and plumbing design; commissioning; energy performance, management, and optimization; building program management; acoustical design consulting; and audiovisual–security and surveillance–information technology–data center services, as well as energy services. Further, it provides various services, such as investigating and analyzing environmental conditions, and recommending corrective measures and procedures; occupational health and safety services; radiation exposure and protection, and nuclear safety and industrial hygiene analyses services; hydrogeological modeling and environmental programs; water resource planning, monitoring, and environmental management of wastewater facilities; solid waste landfill investigations; permitting and compliance; storm water pollution; environmental impact statement support; agricultural waste management and permitting; and wetland evaluations. The company was formerly known as NV5 Holdings, Inc. and changed its name to NV5 Global, Inc. in December 2015. NV5 Global, Inc. was founded in 1949 and is headquartered in Hollywood, Florida.
Earnings Per Share
As for profitability, NV5 Global has a trailing twelve months EPS of $3.07.
PE Ratio
NV5 Global has a trailing twelve months price to earnings ratio of 36.13. Meaning, the purchaser of the share is investing $36.13 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.96%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
NV5 Global’s EBITDA is 77.23.
Volume
Today’s last reported volume for NV5 Global is 2150 which is 97.89% below its average volume of 101895.
2. Ingersoll (IR)
16.2% sales growth and 7.05% return on equity
Ingersoll Rand Inc. provides various mission-critical air, fluid, energy, specialty vehicle, and medical technologies in the United States, Europe, the Middle East, India, Africa, and the Asia Pacific. It operates through two segments, Industrial Technologies and Services, and Precision and Science Technologies. The Industrial Technologies and Services segment designs, manufactures, markets, and services air and gas compression, vacuum, and blower products; fluid transfer equipment and loading systems; and power tools and lifting equipment, including associated aftermarket parts, consumables, air treatment equipment, controls, other accessories, and services under the under the Ingersoll Rand, Gardner Denver, Nash, CompAir, Elmo Rietschle, Robuschi, Emco Wheaton, and Runtech Systems brands. The Precision and Science Technologies segment designs, manufactures, and markets diaphragm, piston, water-powered, peristaltic, gear, vane, progressive cavity, and syringe pumps; and gas boosters, hydrogen compression systems, automated liquid handling systems, odorant injection systems, controls, software, and other related components and accessories for liquid and gas dosing, transfer, dispensing, compression, sampling, pressure management, and flow control in specialized or critical applications under the Air Dimensions, Albin, ARO, Dosatron, Haskel, LMI, Maximus, Milton Roy, MP, Oberdorfer, Seepex, Thomas, Welch, Williams, YZ, and Zinnser Analytic brand names. This segment's products are used in medical, life sciences, industrial manufacturing, water and waste water, chemical processing, energy, food and beverage, agriculture, and other markets. It sells through an integrated network of direct sales representatives and independent distributors. The company was formerly known as Gardner Denver Holdings, Inc. and changed its name to Ingersoll Rand Inc. in March 2020. Ingersoll Rand Inc. was founded in 1859 and is headquartered in Davidson, North Carolina.
Earnings Per Share
As for profitability, Ingersoll has a trailing twelve months EPS of $1.58.
PE Ratio
Ingersoll has a trailing twelve months price to earnings ratio of 41.17. Meaning, the purchaser of the share is investing $41.17 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.05%.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on May 22, 2023, the estimated forward annual dividend rate is 0.08 and the estimated forward annual dividend yield is 0.12%.
Previous days news about Ingersoll(IR)
- According to Zacks on Monday, 31 July, "Below we have discussed industrial companies like Emerson Electric Co. (EMR Quick QuoteEMR – Free Report) , Ingersoll Rand (IR Quick QuoteIR – Free Report) , Illinois Tool Works Inc. (ITW Quick QuoteITW – Free Report) and Johnson Controls International (JCI Quick QuoteJCI – Free Report) that are set to trump earnings estimates this reporting cycle.", "Solid underlying demand and higher orders across the product portfolio of compressors and power tools and lifting are expected to have buoyed Ingersoll Rand’s performance. "
3. Option Care Health (OPCH)
8.4% sales growth and 12.4% return on equity
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides immunoglobulin infusion therapies for the treatment of immune deficiencies; anti-infective therapies and services; home infusion services to treat heart failures; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders; and immunoglobulin infusion therapies. It also offers infusion therapies for bleeding disorders; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications. In addition, the company offers therapies that women need to survive and thrive through high-risk pregnancies; treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; and nursing services. The company is headquartered in Bannockburn, Illinois.
Earnings Per Share
As for profitability, Option Care Health has a trailing twelve months EPS of $0.86.
PE Ratio
Option Care Health has a trailing twelve months price to earnings ratio of 38.3. Meaning, the purchaser of the share is investing $38.3 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.4%.
Sales Growth
Option Care Health’s sales growth is 8.4% for the current quarter and 8.4% for the next.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 15.8% and 14.3%, respectively.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Option Care Health’s EBITDA is 78.9.
Yearly Top and Bottom Value
Option Care Health’s stock is valued at $32.94 at 20:22 EST, below its 52-week high of $35.87 and way above its 52-week low of $24.23.
4. ITT Corporation (ITT)
8.1% sales growth and 18.01% return on equity
ITT Inc. manufactures and sells engineered critical components and customized technology solutions for the energy, transportation, and industrial markets worldwide. The company operates through three segments: Motion Technologies, Industrial Process, and Connect & Control Technologies. The Motion Technologies segment manufactures brake pads, shims, shock absorbers, and energy absorption components; and sealing technologies primarily for the transportation industry, including passenger cars, light- and heavy-duty commercial and military vehicles, buses, and rail. The Industrial Process segment designs and manufactures industrial pumps, valves, and plant optimization systems; and centrifugal process pumps, twin screw, axials, and positive displacement pumps, and water systems, as well as aftermarket solutions, such as repairs and upgrades services. It serves various customers in industries, such as chemical, oil and gas, mining, and other industrial process markets. The Connect & Control Technologies segment designs and manufactures a range of engineered connectors and specialized control components for critical applications supporting various markets, including aerospace and defense, industrial, transportation, medical, and oil and gas. The connector product portfolio includes electrical connectors, such as circular, rectangular, radio frequency, fiber optic, D-sub miniature, micro-miniature, and cable assemblies; and control products consist of fuel and water pumps, valves, electro-mechanical rotary and linear actuators, and pressure, temperature, limit, and flow switches for various aircraft systems. ITT Inc. was founded in 1920 and is headquartered in White Plains, New York.
Earnings Per Share
As for profitability, ITT Corporation has a trailing twelve months EPS of $4.72.
PE Ratio
ITT Corporation has a trailing twelve months price to earnings ratio of 20.96. Meaning, the purchaser of the share is investing $20.96 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.01%.
Moving Average
ITT Corporation’s worth is way above its 50-day moving average of $89.32 and way higher than its 200-day moving average of $84.74.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 20.4% and 2.5%, respectively.
